In CRC, YTHDF2 can increase the m6A modification of GSK3β mRNA, reduce the stability of GSK3β mRNA, and promote its degradation, which induces CRC cell proliferation and tumor progression (68). The gene discussed is GSK3B; the disease is colorectal carcinoma.